Prevo, R., Deutsch, E., Sampson, O., Diplexcito, J., Cengel, K., Harper, J., . . . Bernhard, E. J. (2008). Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity. Cancer research (Chicago, Ill.), 68(14), 5915. https://doi.org/10.1158/0008-5472.CAN-08-0757
Chicago-Zitierstil (17. Ausg.)Prevo, Remko, et al. "Class I PI3 Kinase Inhibition by the Pyridinylfuranopyrimidine Inhibitor PI-103 Enhances Tumor Radiosensitivity." Cancer Research (Chicago, Ill.) 68, no. 14 (2008): 5915. https://doi.org/10.1158/0008-5472.CAN-08-0757.
MLA-Zitierstil (9. Ausg.)Prevo, Remko, et al. "Class I PI3 Kinase Inhibition by the Pyridinylfuranopyrimidine Inhibitor PI-103 Enhances Tumor Radiosensitivity." Cancer Research (Chicago, Ill.), vol. 68, no. 14, 2008, p. 5915, https://doi.org/10.1158/0008-5472.CAN-08-0757.